Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2017, Article ID 8758623, 7 pages
https://doi.org/10.1155/2017/8758623
Research Article

Correlation of Ezrin Expression Pattern and Clinical Outcomes in Ewing Sarcoma

1Department of Pediatrics, Emory University, Children’s Healthcare of Atlanta, Health Sciences Research Building, Brumley Bridge, 3rd Floor, W-350, 1760 Haygood Drive, Atlanta, GA 30322, USA
2Department of Pathology, Emory University, Children’s Healthcare of Atlanta, 1405 Clifton Road NE, Atlanta, GA 30322, USA
3Department of Pediatrics, Emory University, Children’s Healthcare of Atlanta, Health Sciences Research Building, Brumley Bridge, 4th Floor, W-440-B, 1760 Haygood Drive, Atlanta, GA 30322, USA
4Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA
5Department of Pediatrics, Emory University, Children’s Healthcare of Atlanta, 1405 Clifton Road NE, Atlanta, GA 30322, USA
6Department of Pediatrics, Vanderbilt University, Monroe Carell Jr. Children’s Hospital at Vanderbilt, 2220 Pierce Avenue, 396c Preston Research Building, Nashville, TN 37232, USA
7Department of Pediatrics, Emory University, Children’s Healthcare of Atlanta, Health Sciences Research Building, Brumley Bridge, 4th Floor, W-470, 1760 Haygood Drive, Atlanta, GA 30322, USA

Correspondence should be addressed to Thomas Cash; gro.aohc@hsac.samoht

Received 23 September 2016; Revised 12 December 2016; Accepted 29 December 2016; Published 26 January 2017

Academic Editor: Dae-Geun Jeon

Copyright © 2017 Thomas Cash et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

The Supplementary Material includes two tables. Supplemental Table 1 shows a comparison of the 5-year event-free survival among different ezrin expression groups for patients with localized disease, while Supplemental Table 2 shows the same comparisons for patients with metastatic disease.

  1. Supplementary Material